Comment on Kopańska et al. Disorders of the Cholinergic System in COVID-19 Era—A Review of the Latest Research. Int. J. Mol. Sci. 2022, 23, 672
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Kopańska, M.; Batoryna, M.; Bartman, P.; Szczygielski, J.; Banaś-Ząbczyk, A. Disorders of the Cholinergic System in COVID-19 Era—A Review of the Latest Research. Int. J. Mol. Sci. 2022, 23, 672. [Google Scholar] [CrossRef] [PubMed]
- Farsalinos, K.; Eliopoulos, E.; Leonidas, D.D.; Papadopoulos, G.E.; Tzartos, S.; Poulas, K. Nicotinic cholinergic system and COVID-19: In silico identification of an interaction between SARS-CoV-2 and nicotinic receptors with potential therapeutic targeting implications. Int. J. Mol. Sci. 2020, 21, 5807. [Google Scholar] [CrossRef] [PubMed]
- Cafiero, C.; Micera, M.; Re, A.; Postiglione, L.; Cacciamani, A.; Schiavone, B.; Benincasa, G.; Palmirotta, R. Could Small Neurotoxins-Peptides be Expressed during SARS-CoV-2 Infection? Curr. Genom. 2021, 22, 557–563. [Google Scholar] [CrossRef]
- Sola, I.; Almazán, F.; Zúñiga, S.; Enjuanes, L. Continuous and discontinuous RNA synthesis in coronaviruses. Annu. Rev. Virol. 2015, 2, 265–288. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Romano, M.; Ruggiero, A.; Squeglia, F.; Maga, G.; Berisio, R. A structural view of SARS-CoV-2 RNA replication machinery: RNA synthesis, proofreading and final capping. Cells 2020, 9, 1267. [Google Scholar] [CrossRef] [PubMed]
- Sastry, B.V. Cholinergic systems and multiple cholinergic receptors in ocular tissues. J. Ocul. Pharmacol. 1985, 1, 201–226. [Google Scholar] [CrossRef] [PubMed]
- Leonardi, A.; Rosani, U.; Brun, P. Ocular Surface Expression of SARS-CoV-2 Receptors. Ocul. Immunol. Inflamm. 2020, 28, 735–738. [Google Scholar] [CrossRef] [PubMed]
- Kumar, S.; Thambiraja, T.S.; Karuppanan, K.; Subramaniam, G. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein. J. Med. Virol. 2022, 94, 1641–1649. [Google Scholar] [CrossRef] [PubMed]
- Li, C.X.; Chen, J.; Lv, S.K.; Li, J.H.; Li, L.L.; Hu, X. Whole-transcriptome RNA sequencing reveals significant differentially expressed mRNAs, miRNAs, and lncRNAs and related regulating biological pathways in the peripheral blood of COVID-19 patients. Mediat. Inflamm. 2021, 2021, 6635925. [Google Scholar] [CrossRef] [PubMed]
- Petrillo, M.; Brogna, C.; Cristoni, S.; Querci, M.; Piazza, O.; Van den Eede, G. Increase of SARS-CoV-2 RNA load in faecal samples prompts for rethinking of SARS-CoV-2 biology and COVID-19 epidemiology. F1000 Research 2021, 10, 370. [Google Scholar] [CrossRef] [PubMed]
- Bischoff, S.C. Microbiota and aging. Curr. Opin. Clin. Nutr. Metab. Care 2016, 19, 26–30. [Google Scholar] [CrossRef] [PubMed]
- Li, J.J.; Yi, S.; Wei, L. Ocular microbiota and intraocular inflammation. Front. Immunol. 2020, 11, 609765. [Google Scholar] [CrossRef] [PubMed]
- Zhang, D.; Li, S.; Wang, N.; Tan, H.Y.; Zhang, Z.; Feng, Y. The cross-talk between gut microbiota and lungs in common lung diseases. Front. Microbiol. 2020, 11, 301. [Google Scholar] [CrossRef] [PubMed]
- Ventero, M.P.; Cuadrat, R.R.C.; Vidal, I.; Andrade, B.G.N.; Molina-Pardines, C.; Haro-Moreno, J.M.; Coutinho, F.H.; Merino, E.; Regitano, L.C.A.; Silveira, C.B.; et al. Nasopharyngeal microbial communities of patients infected with SARS-CoV-2 that developed COVID-19. Front. Microbiol. 2021, 12, 637430. [Google Scholar] [CrossRef] [PubMed]
- Ferreira, C.; Viana, S.D.; Reis, F. Gut Microbiota dysbiosis-immune hyperresponse-inflammation triad in coronavirus disease 2019 (COVID-19): Impact of pharmacological and nutraceutical approaches. Microorganisms 2020, 8, 1514. [Google Scholar] [CrossRef] [PubMed]
- De Oliveira, G.L.V.; Oliveira, C.N.S.; Pinzan, C.F.; De Salis, L.V.V.; Cardoso, C.R.B. Microbiota modulation of the gut-lung axis in COVID-19. Front. Immunol. 2021, 12, 635471. [Google Scholar] [CrossRef] [PubMed]
- Di Stadio, A.; Costantini, C.; Renga, G.; Pariano, M.; Ricci, G.; Romani, L. The microbiota/host immune system interaction in the nose to protect from COVID-19. Life 2020, 10, 345. [Google Scholar] [CrossRef]
- Sundararaman, A.; Ray, M.; Ravindra, P.V.; Halami, P.M. Role of probiotics to combat viral infections with emphasis on COVID-19. Appl. Microbiol. Biotechnol. 2020, 104, 8089–8104. [Google Scholar] [CrossRef]
- Kim, D.; Lee, J.Y.; Yang, J.S.; Kim, J.W.; Kim, V.N.; Chang, H. The architecture of SARS-CoV-2 transcriptome. Cell 2020, 181, 914–921.e10. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Cafiero, C.; Micera, A.; Re, A.; Schiavone, B.; Benincasa, G.; Palmirotta, R. Comment on Kopańska et al. Disorders of the Cholinergic System in COVID-19 Era—A Review of the Latest Research. Int. J. Mol. Sci. 2022, 23, 672. Int. J. Mol. Sci. 2022, 23, 2818. https://doi.org/10.3390/ijms23052818
Cafiero C, Micera A, Re A, Schiavone B, Benincasa G, Palmirotta R. Comment on Kopańska et al. Disorders of the Cholinergic System in COVID-19 Era—A Review of the Latest Research. Int. J. Mol. Sci. 2022, 23, 672. International Journal of Molecular Sciences. 2022; 23(5):2818. https://doi.org/10.3390/ijms23052818
Chicago/Turabian StyleCafiero, Concetta, Alessandra Micera, Agnese Re, Beniamino Schiavone, Giulio Benincasa, and Raffaele Palmirotta. 2022. "Comment on Kopańska et al. Disorders of the Cholinergic System in COVID-19 Era—A Review of the Latest Research. Int. J. Mol. Sci. 2022, 23, 672" International Journal of Molecular Sciences 23, no. 5: 2818. https://doi.org/10.3390/ijms23052818